Founded Year

2020

Stage

Incubator/Accelerator - II | Alive

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+11 points in the past 30 days

About Deliberate AI

Deliberate AI focuses on the application of artificial intelligence in the healthcare sector, specifically in the assessment of psychiatric and neurological health. The company's main service involves the extraction of features from audio-visual signals and other modalities to compute clinically significant biomarkers and predictive models for psychiatric and neurologic disorders. Its services primarily cater to the life sciences industry, including biopharma and medical device companies. It was founded in 2020 and is based in New York, New York.

Headquarters Location

1562 1st Avenue Suite 205-3059

New York, New York, 10028,

United States

Loading...

Deliberate AI's Product Videos

ESPs containing Deliberate AI

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Monitoring, Imaging & Diagnostics Tech

The mental health voice biomarkers market offers solutions to diagnose mental issues by monitoring changes in speech patterns. These companies use machine learning to analyze vocal patterns to detect changes in a person’s mood, emotion, and mental state over time, providing clinicians with data for more precise and accurate diagnoses. The market also aims to improve patient outcomes, reduce health…

Deliberate AI named as Challenger among 9 other companies, including Sonde Health, Ellipsis Health, and Canary Speech.

Deliberate AI's Products & Differentiators

    mutitude™

    Multimodal machine learning platform for computational biomarker and phenotyping discovery and validation

Loading...

Research containing Deliberate AI

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Deliberate AI in 1 CB Insights research brief, most recently on Sep 13, 2023.

Expert Collections containing Deliberate AI

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Deliberate AI is included in 1 Expert Collection, including Artificial Intelligence (AI).

A

Artificial Intelligence (AI)

20,629 items

Latest Deliberate AI News

HITLAB Announces Finalists for Fall 2022 Breakthrough Alliance Challenge

Jun 16, 2025

HITLAB TEAM • November 23, 2022 Five finalists to present solutions to panel of judges during November Innovator’s Summit November 23, 2022 – Today, HITLAB announced the 5 finalists selected for the Fall 2022 Breakthrough Alliance (BTA) Innovator’s challenge. The BTA is a digital health consortium which was created to accelerate a greater number of innovations to improve health outcomes and care delivery through verified emerging technologies. The finalists, which were selected based on innovation, scalability, sustainability and impact of their solution, include Genus, Deliberate AI, Rubitection, Evva Health and Conversio Health. There were hundreds of applications from around the world. Each was reviewed and scored by a panel of independent judges and Breakthrough Board Members. All 5 companies will have a chance to present their digital health solutions on November 29th during the HITLAB 2022 Innovator’s Summit. Three tiers of winners will be selected. The winning solutions will be evaluated in validation studies conducted by the HITLAB Research and Evaluation team. They will also receive an opportunity to present with other industry leaders at one of HITLAB’s monthly Digital Health Symposia. The 1st and 2nd winners will receive published articles. “This semester, we had the highest number of applicants for the Breakthrough Alliance Challenge. It was a truly an amazing pool of applicants proving that innovation for digital health is not going anywhere.” said Stan Kachnowski, Chair of HITLAB and Director Digital Health Program, Columbia Business School. “While it was very difficult to choose the finalists, the 5 digital health solutions that were selected address current gaps in healthcare and fulfill unmet needs in the marketplace.” Summary of Finalists/Solutions: Genus Connect – provides a content delivery system that empowers patients and caregivers with insights and affirmations for better care. Curated and engaging, content is delivered at the right time, with real-time feedback and validation to help improve outcomes and unite resources across the continuum of care. Deliberate AI –provides a data-driven multimodal assessment of psychiatric and neurological health for clinical trials and healthcare. Rubitection – an AI enabled platform for the assessment and care of chronic wounds. Supports early detection and management of pressure injuries, diabetic foot ulcers and post-surgical wounds helping to reduce costs and save lives. Conversio Health – a comprehensive disease management program designed   improve care, adherence and cost associated with chronic respiratory conditions. They offer a high touch, tech-enabled program that includes an analytics driven pharmacotherapy service model, low-cost nebulizer medications across all drug classes and innovative DME to drive end to end care delivery for chronic respiratory patients. Evva Health – an AI-driven platform for caregivers of persons with dementia, providing personalized guidance (clinical, behavioral financial) care management and coordination to deliver best community-led care at home. Join HITLAB on November 29th at Columbia University’s Lerner Hall in New York City to watch the finalists present their solutions and see who the three final winners will be. You can register/secure tickets here and find more info here about speakers, agenda and more. All guests must have a valid ticket. ‍ABOUT HITLAB Established in 1998, HITLAB is a leading evidence-based, healthcare innovation lab specializing in the delivery of world-class digital health research and education. We help leading organizations ideate, create, and evaluate technology-based solutions to pressing healthcare challenges across the globe. HITLAB works with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery. ABOUT HITLAB BREAKTHROUGH ALLIANCE HITLAB Breakthrough Alliance was created in collaboration with the New York City Economic Development Corporation to foster the New York City digital health ecosystem and to accelerate a greater number of digital health innovations through the generation of exclusive, evidence-based research and insights. This new digital health consortium is a subscription-based service with a mission to improve health outcomes and care delivery from verifying emerging technologies and research—driven by the perspectives and strategies of its members. Press Contact:

Deliberate AI Frequently Asked Questions (FAQ)

  • When was Deliberate AI founded?

    Deliberate AI was founded in 2020.

  • Where is Deliberate AI's headquarters?

    Deliberate AI's headquarters is located at 1562 1st Avenue, New York.

  • What is Deliberate AI's latest funding round?

    Deliberate AI's latest funding round is Incubator/Accelerator - II.

  • Who are the investors of Deliberate AI?

    Investors of Deliberate AI include One Mind Accelerator, Ulu Ventures and PharmStars.

  • Who are Deliberate AI's competitors?

    Competitors of Deliberate AI include Ellipsis Health and 4 more.

  • What products does Deliberate AI offer?

    Deliberate AI's products include mutitude™ and 1 more.

Loading...

Compare Deliberate AI to Competitors

Sonde Health Logo
Sonde Health

Sonde Health specializes in health technology and focuses on voice-enabled symptom detection and monitoring within the healthcare sector. The company offers a platform that analyzes vocal features to assess mental, cognitive, and respiratory health, providing actionable insights for early detection and management of health conditions. It was founded in 2015 and is based in Boston, Massachusetts.

Ellipsis Health Logo
Ellipsis Health

Ellipsis Health provides health case management solutions using machine learning within the healthcare sector. It was founded in 2017 and is based in San Francisco, California.

Vocalis Health Logo
Vocalis Health

Vocalis Health is a vocal biomarker company using voice to detect, diagnose, and monitor patient health. Its technology leverages machine learning (ML) and deep learning (DL) techniques to analyze voice recordings for insights regarding various health conditions via a mobile application and web browser. The company was founded in 2019 and is based in Newton, Massachusetts.

Modality.AI Logo
Modality.AI

Modality.AI is a company that assesses neurological and psychiatric conditions using a multimodal platform in the clinical research sector. The company provides automated analysis of speech, facial expressions, and motor functions for clinical trials, both in-clinic and remotely, without requiring specialized equipment or personnel. Modality.AI serves the pharmaceutical and biotechnology industries by offering tools for clinical assessments. It was founded in 2018 and is based in San Francisco, California.

Kintsugi Logo
Kintsugi

Kintsugi focuses on mental health care within the healthcare industry. The company offers an application programming interface (API)-first platform that uses voice biomarker technology to identify and prioritize mental health challenges, integrating with various healthcare systems to facilitate timely care. Kintsugi primarily serves the healthcare sector, providing tools for telehealth, call centers, and remote patient monitoring. It was founded in 2019 and is based in Berkeley, California.

TQIntelligence Logo
TQIntelligence

TQIntelligence (TQI) offers an artificial intelligence (AI)-powered pediatric mental health platform operating in the healthcare technology sector. The company specializes in using voice analysis to screen and triage emotional distress in children, aiding mental health care professionals in determining the appropriate level of care. TQIntelligence's technology is designed to support clinicians, particularly in underserved communities, by leveraging the scientific relationship between trauma, stress, and the human voice. It was founded in 2016 and is based in Atlanta, Georgia.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.